Metropolis Healthcare Limited (METROPOLIS)
Press Release
Press Release - Q1FY27
- Revenue 450 Cr +17% y-y; EBITDA 113 Cr +27% y-y; PAT 57 Cr +26% y-y
- Patient volume grew 10% and test volume 11% y-y, driven by market penetration
- B2C revenue up 18% and B2B revenue up 15% y-y
- TruHealth revenue grew 22% to 81 Cr; Specialty revenue up 17% to 178 Cr
- Tier III cities fastest growing with ~25% revenue growth y-y
- EBITDA margin expanded 210 bps to 25.2%; PAT margin improved 90 bps to 12.6%
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 METROPOLIS — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add METROPOLIS to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Metropolis Healthcare Limited
Important.
The summary above is generated automatically from Metropolis Healthcare Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.